The insulin-like growth factors (IGFs) are mitogenic polypeptides that have been linked to a variety of normal physiological processes as well as neoplasia. Overexpression of several components of the IGF system is associated with hepatocarcinogenesis in humans and rodents. In rat liver, diets rich in n-6 polyunsaturated fatty acid (PUFA) enhance the development of preneoplastic lesions and tumors. Therefore, the objective of this study was to determine the effect of these dietary fatty acids on the hepatic expression of the various components of the IGF system. The mRNA levels of IGF-1 and the type 1 receptor were not different in livers of rats fed a diet containing 20% corn oil (CO) compared with those fed 5% CO. Analysis of the IGF binding proteins revealed that insulin-like growth factor binding protein-1 (IGFBP-1) levels were altered by the amount and type of dietary fat A 2.5-fold induction of IGFBP-1 mRNA occurred within 1 week after the animals were fed the 20% corn oil diet compared with those fed 5% CO and was further enhanced to over 6-fold after 1 month. Furthermore, IGFBP-1 protein was only detectable in the livers of animals fed the 20% CO diet Induction of IGFBP-1 mRNA (4.5-fold) also occurred in rats fed a high-fat diet containing safflower (rich in n-6 PUFAs) compared with those fed a high-fat diet containing menhaden oil (rich in n-3 PUFAs). The induction of IGFBP-1 mRNA was independent of serum insulin levels and the development of insulin resistance. Since IGFBP-1 mRNA is upregulated in regenerating liver, we reasoned that the induction of IGFBP-1 mRNA may be associated with an increase in cell proliferation; however, no difference was observed in the hepatic labeling Index of rats fed the 20% CO compared with the 5% CO diet. In summary, these studies show a striking induction by dietary n-6 PUFAs of hepatic IGFBP-1, a protein that has been Implicated in liver cancer development.
Get full access to this article
View all access options for this article.
References
1.
FayMP, FreedmanLS, CliffordCK, MidthuneDN. Effect of different types and amounts of fat on the development of mammary tumors in rodents: A review. Cancer Res57: 3979–3988, 1997.
2.
HietanenE, BartschH, BereziatJ-C, AhotupaM, CamusA-M, CabraiJRP, LaitinenM.Quantity and saturation degree of dietary fats as modulators of oxidative stress and chemically induced liver rumors in rats. Int J Cancer46: 640–647, 1990.
3.
HechtJR. Dietary fat and colon cancer. Adv Exp Med Biol399: 157–163, 1996.
4.
BaldwinS, ParkerRS. The effects of dietary fat and selenium on the development of preneoplastic lesions in rat liver. Nutr Cancer8: 273–282, 1986.
5.
McCayPB, KingM, RikansLE, PithaJV. Interactions between dietary fats and antioxidants on DMBA-induced mammary carcinomas and on AAF-induced hyperplastic nodules and hepatomas. J Environ Pathol Toxicol3: 451–465, 1980.
6.
BaldwinS, ParkerRS. Influence of dietary fat and selenium in initiation and promotion of aflatoxin B1-induced preneoplastic foci in rat liver. Carcinogenesis8: 101–107, 1987.
7.
GlauertHP, PitotHC. Influence of dietary fat on the promotion of diethylnitrosamine-induced hepatocarcinogenesis in female rats. Proc Soc Exp Biol Med181: 498–506, 1986.
8.
RahmanKMW, SugieS, OkamotoK, WatanabeT, TanakaT, MoriH.Modulating effects of diets high in ω-3 and ω-6 fatty acids in initiation and postinitiation stages of diethylnitrosamine-induced hepatocarcinogenesis in rats. Jpn J Cancer Res90: 31–39, 1999.
9.
ChenH-W, KoJ-J, LiiC-K, OuC-C, SheenL-Y.Corn oil enhances γ-glutamyl transpeptidase-positive foci development in the presence of phenobarbital during hepatocarcinogenesis in rats. Nutr Cancer28: 252–257, 1997.
10.
ShinozukaH, TakahashiS, LombardiB, AbanobiSE. Effects of varying the fat content of a choline-devoid diet on promotion of the emergence of γ-glutamyl-transpeptidase positive foci in the liver of carcinogen-treated rats. Cancer Lett16: 43–50, 1982.
11.
PelikanovaT, KohoutM, ValekJ, BaseJ, KazdovaL.Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men. Metabolism38: 188–192, 1989.
12.
BruningPF, BonfrerJMG, van NoordPAH, HartAAM, De Jong-BakkerM, NooijenWJ. Insulin resistance and breast cancer risk. Int J Cancer52: 511–516, 1992.
13.
StollBA. Essential fatty acids, insulin resistance, and breast cancer risk. Nutr Cancer31: 72–77, 1998.
14.
McKeown-EyssenG.Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk?Cancer Epidemiol Biomarkers Prev3: 687–695, 1994.
15.
GiovannucciE.Insulin and colon cancer. Cancer Causes Control6: 164–179, 1995.
16.
LagopoulosL, SunaharaGI, WurznerH, DombrowskyI, StalderR.The effects of alternating dietary restriction and ad libitum feeding of mice on the development of diethylnitrosamine-induced liver tumours and its correlation to insulinaemeia. Carcinogenesis12: 311–315, 1991.
17.
StewartCE, RotweinP.Growth, differentiation, and survival: Multiple physiological functions for insulin-like growth factors. Physiol Rev76: 1005–1026, 1996.
18.
RankeMB, ElmlingerM.Functional role of insulin-like growth factor binding proteins. Horm Res48(Suppl 4): 9–15, 1997.
19.
JonesJI, ClemmonsDR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev16: 3–34, 1995.
20.
OhY, RosenfeldRG. IGF-independent actions of the IGF binding proteins. In: RosenfeldRG, RobertsCT Eds. The IGF System. Totowa, NJ: Humana Press, Inc., p 257, 1999.
21.
RoglerCE, YangD, RossettiL, DonohoeJ, AltE, ChangCJ, RosenfeldR, NeelyK, HintzR.Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem269: 13779–13784, 1994.
22.
CarianiE, SasserreC, SeurinD, HamelinB, KemenyF, FrancoD, CzechMP, UllrichA., BrechotC.Differential expression of insulinlike growth factor-H mRNA in human primary liver cancer, benign liver tumors, and liver cirrhosis. Cancer Res48: 6844–6849, 1988.
23.
D'arvilleCN, Nouri-AriaKT, JohnsonP, WilliamsR.Regulation of insulin-like growth factor-II gene expression by hepatitis B virus in hepatocellular carcinoma. Hepatology16: 1362–1366, 1991.
24.
NorstedtG, LevinovitzA, MollerC, ErikssonLC, AnderssonG.Expression of insulin-like growth factor-I (IGF-I) and IGF-II mRNA during hepatic development, proliferation, and carcinogenesis in the rat. Carcinogenesis9: 209–213, 1988.
25.
KimS-O, ParkJ-G, LeeYI. Increased expression of the insulin-like growth factor-I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: Implications of IGF-I receptor gene activation by hepatitis B virus X gene product. Cancer Res56: 3831–3836, 1996.
26.
UntermanTG, OehlerDT, GotwayMB, MorrisPW. Production of the rat type I insulin-like growth factor-binding protein by well-differentiated H4EIIC3 hepatoma cells: Identification, purification, and N-terminal amino acid analysis. Endocrinology127: 789–797, 1990.
27.
KondohN, WakatsukiT, RyoA, HadaA, AhiaraT, HoriuchiS, GosekiN, MatsubaraO, TakenakaK, ShichitaM, TanakaK, ShudaM, YamammotoM.Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res59: 4990–4996, 1999.
28.
BrownT, MackeyK.Analysis of RNA by Northern and Slot blot hybridization. In: AusbelFM, BrentR, KingstonRE, MooreDD, SeidmanJG, SmithJG, StruhlK Eds. Current Protocols in Molecular Biology. Boston: John Wiley and Sons, Inc., Vol. 1: pp4.9.1–4.9.16, 1993.
29.
ShimatsuA, RotweinP.Sequence of two rat insulin-like growth factor mRNAs differing within the 5′ untranslated region. Nucleic Acids Res15: 7196, 1987.
30.
BrownAL, ChiariottiL, OrlowskiCC, MehlmanT, BurgessWH, AckermanEJ, BruniCB, RechlerMM. Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors. J Biol Chem264: 5148–5154, 1989.
31.
WernerH, WoloschakM, AdamoM, Shen-OrrZ, RobertsCTJr.., LeRoithD.Developmental regulation of the rat insulin-like growth factor-I receptor gene. Proc Natl Acad Sci U S A86: 7451–7455, 1989.
32.
MurphyLJ, SeneviratneC, BallejoG, CrozeF, KennedyTG. Identification and characterization of a rat decidual insulin-like growth factor-binding protein complementary DNA. Mol Endrocrinol4: 329–336, 1990.
33.
ShimasakiS, UchiyamaF, ShimonakaM, LingN.Molecular cloning of the cDNAs encoding a novel insulin-like growth factor-binding protein from rat and human. Mol Endocrinol4: 1451–1458, 1990.
34.
LaemmliUK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature227: 680–685, 1970.
35.
WoodGA, KorkolaJE, LeeVM, SarmaDSR, ArcherMC. Resistance of Copenhagen rats to chemical induction of glutathione S-transferase 7–7-positive liver foci. Carcinogenesis18: 1745–1750, 1997.
36.
RechlerMM, OoiGT, SuhD, TsengL.Rapid regulation of insulin-like growth factor binding protein-1 transcription by insulin in vivo and in vitro.Adv Exp Med Biol343: 227–236, 1993.
37.
OakesND, CooneyGJ, CamilleriS, ChisholmDJ, KraegenEW. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes46: 1768–1774, 1997.
38.
SternJ, JohnsonPR, GreenwoodMR, ZuckerLM, HirschJ.Insulin resistance and pancreatic insulin release in the genetically obese Zucker rat. Proc Soc Exp Biol Med139: 66–69, 1972.
39.
MohnKL, MelbyAE, TewariDS, LazTM, TaubR.The gene encoding rat insulin-like growth factor-binding protein-1 is rapidly and highly induced in regenerating liver. Mol Cell Biol11: 1393–1401, 1991.
40.
HaberBA, MohnKL, DiamondRH, TaubRJ. Induction patterns of 70 genes during 9 days after hepatectomy define the temporal course of liver regeneration. Clin Investig91: 1319–1326, 1993.
41.
LeeJ, GreenbaumL, HaberBA, NagleD, LeeV, MilesV, MohnKL, BucanM, TaubR.Structure and localization of the IGFBP-I gene and its expression during liver regeneration. Hepatology19: 656–665, 1994.
42.
McCartyMF. Upregulation of IGF binding protein-1 as an anticarcinogenic strategy: Relevance to caloric restriction, exercise, and insulin sensitivity. Med Hypotheses48: 297–308, 1997.
